Michael S. Perry, a director at Arrowhead Pharmaceuticals ($ARWR), made one open market sale of company shares in the last year, totaling nearly $1 million. His most recent sale occurred on December 5, 2025. These sales rank 4,953rd among 11,678 individual insiders, compared to an average sale value of $8.6 million across 6.37 transactions. Perry recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | PERRY MICHAEL S | Director | A | Common Stock | 7819 | $0.00 | 123,059.0000 | 133,758,000 | 6.78% | 0.01% |
| Dec. 5, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | PERRY MICHAEL S | Director | S | Common Stock | 16250 | $61.03 | 115,240.0000 | 133,758,000 | 12.36% | 0.01% |
| Dec. 18, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | PERRY MICHAEL S | Director | A | Common Stock | 16733 | $22.99 | 131,490.0000 | 119,784,000 | 14.58% | 0.01% |